Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Seagen stock | $171.43

Learn how to easily invest in Seagen stock.

Seagen Inc is a biotechnology business based in the US. Seagen shares (SGEN) are listed on the NASDAQ and all prices are listed in US Dollars. Seagen employs 2,092 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Seagen

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SGEN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Seagen stock price (NASDAQ: SGEN)

Use our graph to track the performance of SGEN stocks over time.

Seagen shares at a glance

Information last updated 2021-10-23.
Latest market close$171.43
52-week range$133.20 - $202.60
50-day moving average $163.15
200-day moving average $154.24
Wall St. target price$189.00
PE ratio 53.4883
Dividend yield N/A (0%)
Earnings per share (TTM) $3.21

Buy Seagen shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Seagen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Seagen price performance over time

Historical closes compared with the close of $171.43 from 2021-10-22

1 week (2021-10-18) -0.31%
1 month (2021-09-23) 3.13%
3 months (2021-07-26) 19.86%
6 months (2021-04-26) 16.24%
1 year (2020-10-26) -12.46%
2 years (2019-10-25) 67.05%
3 years (2018-10-26) 210.00%
5 years (2016-10-26) 240.61%

Is Seagen under- or over-valued?

Valuing Seagen stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Seagen's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Seagen's P/E ratio

Seagen's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 53x. In other words, Seagen shares trade at around 53x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Seagen's PEG ratio

Seagen's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 16.4272. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Seagen's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Seagen's EBITDA

Seagen's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $653.3 million.

The EBITDA is a measure of a Seagen's overall financial performance and is widely used to measure a its profitability.

Seagen financials

Revenue TTM $2.4 billion
Operating margin TTM 24.8%
Gross profit TTM $1.1 billion
Return on assets TTM 12.08%
Return on equity TTM 22.95%
Profit margin 25.06%
Book value $18.65
Market capitalisation $31.2 billion

TTM: trailing 12 months

Shorting Seagen shares

There are currently 3.2 million Seagen shares held short by investors – that's known as Seagen's "short interest". This figure is 17.2% up from 2.7 million last month.

There are a few different ways that this level of interest in shorting Seagen shares can be evaluated.

Seagen's "short interest ratio" (SIR)

Seagen's "short interest ratio" (SIR) is the quantity of Seagen shares currently shorted divided by the average quantity of Seagen shares traded daily (recently around 811098.48484848). Seagen's SIR currently stands at 3.96. In other words for every 100,000 Seagen shares traded daily on the market, roughly 3960 shares are currently held short.

However Seagen's short interest can also be evaluated against the total number of Seagen shares, or, against the total number of tradable Seagen shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Seagen's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Seagen shares in existence, roughly 20 shares are currently held short) or 0.0484% of the tradable shares (for every 100,000 tradable Seagen shares, roughly 48 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Seagen.

Find out more about how you can short Seagen stock.

Seagen's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Seagen.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Seagen's total ESG risk score

Total ESG risk: 29.88

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Seagen's overall score of 29.88 (as at 12/31/2018) is nothing to write home about – landing it in it in the 56th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Seagen is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Seagen's environmental score

Environmental score: 1.18/100

Seagen's environmental score of 1.18 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Seagen is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Seagen's social score

Social score: 23.34/100

Seagen's social score of 23.34 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Seagen is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Seagen's governance score

Governance score: 10.36/100

Seagen's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that Seagen is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Environmental, social, and governance (ESG) summary

Seagen Inc was last rated for ESG on: 2019-01-01.

Total ESG score 29.88
Total ESG percentile 55.9
Environmental score 1.18
Environmental score percentile 5
Social score 23.34
Social score percentile 5
Governance score 10.36
Governance score percentile 5

Seagen share dividends

We're not expecting Seagen to pay a dividend over the next 12 months.

Seagen share price volatility

Over the last 12 months, Seagen's shares have ranged in value from as little as $133.2 up to $202.6. A popular way to gauge a stock's volatility is its "beta".

SGEN.US volatility(beta: 0.82)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Seagen's is 0.8238. This would suggest that Seagen's shares are less volatile than average (for this exchange).

Seagen overview

Seagen Inc. , a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of metastatic urothelial cancers; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops Tisotumab Vedotin for metastatic cervical cancer and other solid tumors; ladiratuzumab vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc. ; Genmab A/S; Merck; and SpringWorks Therapeutics, Inc.

Seagen in the news

There are no recent company news

Frequently asked questions

What percentage of Seagen is owned by insiders or institutions?
Currently 0.667% of Seagen shares are held by insiders and 90.393% by institutions.
How many people work for Seagen?
Latest data suggests 2,092 work at Seagen.
When does the fiscal year end for Seagen?
Seagen's fiscal year ends in December.
Where is Seagen based?
Seagen's address is: 21823 30th Drive SE, Bothell, WA, United States, 98021
What is Seagen's ISIN number?
Seagen's international securities identification number is: US81181C1045
What is Seagen's CUSIP number?
Seagen's Committee on Uniform Securities Identification Procedures number is: 812578102

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site